{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:22:54Z","timestamp":1774311774334,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T00:00:00Z","timestamp":1261008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s00259-009-1322-7","type":"journal-article","created":{"date-parts":[[2009,12,16]],"date-time":"2009-12-16T11:10:20Z","timestamp":1260961820000},"page":"742-749","source":"Crossref","is-referenced-by-count":16,"title":["Significance of cardiac sympathetic nervous system abnormality for predicting vascular events in patients with idiopathic paroxysmal atrial fibrillation"],"prefix":"10.1007","volume":"37","author":[{"given":"Yasushi","family":"Akutsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyouichi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jumpei","family":"Suyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Shinozuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Gokan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuharu","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Hamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Tanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youichi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,17]]},"reference":[{"key":"1322_CR1","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1161\/circ.114.4.257","volume":"114","author":"V Fuster","year":"2006","unstructured":"Fuster V, Ryd\u00e9n LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC\/AHA\/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e257\u2013354.","journal-title":"Circulation"},{"key":"1322_CR2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0002-9343(02)01236-6","volume":"113","author":"S Stewart","year":"2002","unstructured":"Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew\/Paisley study. Am J Med 2002;113:359\u201364.","journal-title":"Am J Med"},{"key":"1322_CR3","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.STR.30.6.1223","volume":"30","author":"RG Hart","year":"1999","unstructured":"Hart RG, Pearce LA, McBride R, Rothbart RM, Asinger RW. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Stroke 1999;30:1223\u20139.","journal-title":"Stroke"},{"key":"1322_CR4","doi-asserted-by":"crossref","unstructured":"Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials. Arch Intern Med 1998;158:1316\u201320.","DOI":"10.1001\/archinte.158.12.1316"},{"key":"1322_CR5","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1161\/CIRCULATIONAHA.106.644484","volume":"115","author":"A Jahangir","year":"2007","unstructured":"Jahangir A, Lee V, Friedman PA, Trusty JM, Hodge DO, Kopecky SL, et al. Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study. Circulation 2007;115:3050\u20136.","journal-title":"Circulation"},{"key":"1322_CR6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1008871118641","volume":"7","author":"SL Kopecky","year":"1999","unstructured":"Kopecky SL. Idiopathic atrial fibrillation: prevalence, course, treatment, and prognosis. J Thromb Thrombolysis 1999;7:27\u201331.","journal-title":"J Thromb Thrombolysis"},{"key":"1322_CR7","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1161\/CIRCULATIONAHA.107.709287","volume":"115","author":"L Frost","year":"2007","unstructured":"Frost L. Lone atrial fibrillation: good, bad, or ugly? Circulation 2007;115:3040\u20131.","journal-title":"Circulation"},{"key":"1322_CR8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/B978-0-443-06570-5.50021-6","volume-title":"Electrophysiological disorders of the heart","author":"AJ Camm","year":"2005","unstructured":"Camm AJ, Savelieva I, Bharati SJ, Lindsay BD, Nattel S, Shinagawa K, et al. Atrial tachycardia, flutter, and fibrillation. In: Saksena S, Camm AJ, Boyden PA, Dorian P, Goldschlager N, editors. Electrophysiological disorders of the heart. Philadelphia: Elsevier Health Sciences, Churchill Livingstone; 2005. p. 283\u2013363."},{"key":"1322_CR9","unstructured":"Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fbrillation. Eur Heart J 2009;doi: 10.1093\/eurheart\/ehn599 ."},{"key":"1322_CR10","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/eurheartj\/ehn101","volume":"29","author":"R Nieuwlaat","year":"2008","unstructured":"Nieuwlaat R, Dinh T, Olsson SB, Camm AJ, Capucci A, Tieleman RG, et al. Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation? Eur Heart J 2008;29:915\u201322.","journal-title":"Eur Heart J"},{"key":"1322_CR11","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/01.CIR.97.8.757","volume":"97","author":"KW Mahaffey","year":"1998","unstructured":"Mahaffey KW, Granger CB, Sloan MA, Thompson TD, Gore JM, Weaver WD, et al. Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I. Circulation 1998;97:757\u201364.","journal-title":"Circulation"},{"key":"1322_CR12","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1161\/01.STR.0000260090.90508.3e","volume":"38","author":"GY Lip","year":"2007","unstructured":"Lip GY, Patel JV, Hughes E, Hart RG. High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis. Stroke 2007;38:1229\u201337.","journal-title":"Stroke"},{"key":"1322_CR13","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1007\/s00259-008-0879-x","volume":"35","author":"Y Akutsu","year":"2008","unstructured":"Akutsu Y, Kaneko K, Kodama Y, Li HL, Kawamura M, Asano T, et al. Cardiac sympathetic nerve abnormality predicts ventricular tachyarrhythmic events in patients without conventional risk of sudden death. Eur J Nucl Med Mol Imaging 2008;35:2066\u201373.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1322_CR14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2967\/jnumed.108.055194","volume":"50","author":"Y Akutsu","year":"2009","unstructured":"Akutsu Y, Kaneko K, Kodama Y, Li HL, Kawamura M, Asano T, et al. The significance of cardiac sympathetic nervous system abnormality in the long-term prognosis of patients with a history of ventricular tachyarrhythmia. J Nucl Med 2009;50:61\u20137.","journal-title":"J Nucl Med"},{"key":"1322_CR15","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1093\/eurheartj\/ehi483","volume":"26","author":"M Osranek","year":"2005","unstructured":"Osranek M, Bursi F, Bailey KR, Grossardt BR, Brown RD, Kopecky SL, et al. Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up. Eur Heart J 2005;26:2556\u201361.","journal-title":"Eur Heart J"},{"key":"1322_CR16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"E Kaplan","year":"1958","unstructured":"Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Soc 1958;53:457\u201381.","journal-title":"J Am Stat Soc"},{"key":"1322_CR17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"D Cox","year":"1972","unstructured":"Cox D. Regression models and life tables. J R Stat Soc B 1972;34:187\u2013220.","journal-title":"J R Stat Soc B"},{"key":"1322_CR18","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/hc1102.105261","volume":"105","author":"C Zoccali","year":"2002","unstructured":"Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 2002;105:1354\u20139.","journal-title":"Circulation"},{"key":"1322_CR19","first-page":"1757","volume":"42","author":"T Wakabayashi","year":"2001","unstructured":"Wakabayashi T, Nakata T, Hashimoto A, Yuda S, Tsuchihashi K, Travin MI, et al. Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death. J Nucl Med 2001;42:1757\u201367.","journal-title":"J Nucl Med"},{"key":"1322_CR20","first-page":"917","volume":"40","author":"P Merlet","year":"1999","unstructured":"Merlet P, Benvenuti C, Moyse D, Pouillart F, Dubois-Rand\u00e9 JL, Duval AM, et al. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med 1999;40:917\u201323.","journal-title":"J Nucl Med"},{"key":"1322_CR21","first-page":"1089","volume":"46","author":"M Mabuchi","year":"2005","unstructured":"Mabuchi M, Imamura M, Kubo N, Morita K, Noriyasu K, Tsukamoto T, et al. Sympathetic denervation and reinnervation after the maze procedure. J Nucl Med 2005;46:1089\u201394.","journal-title":"J Nucl Med"},{"key":"1322_CR22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2967\/jnumed.107.042564","volume":"49","author":"D Nagahara","year":"2008","unstructured":"Nagahara D, Nakata T, Hashimoto A, Wakabayashi T, Kyuma M, Noda R, et al. Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function. J Nucl Med 2008;49:225\u201333.","journal-title":"J Nucl Med"},{"key":"1322_CR23","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.HYP.34.4.724","volume":"34","author":"G Mancia","year":"1999","unstructured":"Mancia G, Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organic damage. Hypertension 1999;34:724\u20138.","journal-title":"Hypertension"},{"key":"1322_CR24","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.hrthm.2006.12.006","volume":"4","author":"P Chen","year":"2007","unstructured":"Chen P, Tan AY. Autonomic nerve activity and atrial fibrillation. Heart Rhythm 2007;4:S61\u20134.","journal-title":"Heart Rhythm"},{"key":"1322_CR25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jacc.2004.11.038","volume":"45","author":"S Kasama","year":"2005","unstructured":"Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, et al. Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction. J Am Coll Cardiol 2005;45:661\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"1322_CR26","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jacc.2008.10.025","volume":"53","author":"S Tamaki","year":"2009","unstructured":"Tamaki S, Yamada T, Okuyama Y, Morita T, Sanada S, Tsukamoto Y, et al. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion. J Am Coll Cardiol 2009;53:426\u201335.","journal-title":"J Am Coll Cardiol"},{"key":"1322_CR27","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/S0002-9149(99)00145-9","volume":"83","author":"U Lotze","year":"1999","unstructured":"Lotze U, Kober A, Kaepplinger S, Neubauer S, Gottschild D, Figulla HR. Cardiac sympathetic activity as measured by myocardial 123-I-metaiodobenzylguanidine uptake and heart rate variability in idiopathic dilated cardiomyopathy. Am J Cardiol 1999;83:1548\u201351.","journal-title":"Am J Cardiol"},{"key":"1322_CR28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijcard.2006.04.026","volume":"115","author":"P Korantzopoulos","year":"2007","unstructured":"Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 2007;115:135\u201343.","journal-title":"Int J Cardiol"},{"key":"1322_CR29","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/01.CIR.92.7.1954","volume":"92","author":"MC Wijffels","year":"1995","unstructured":"Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954\u201368.","journal-title":"Circulation"},{"key":"1322_CR30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0735-1097(96)00427-5","volume":"29","author":"H Sohara","year":"1997","unstructured":"Sohara H, Amitani S, Kurose M, Miyahara K. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol 1997;29:106\u201312.","journal-title":"J Am Coll Cardiol"},{"key":"1322_CR31","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1161\/01.CIR.0000103131.70301.4F","volume":"108","author":"RJ Aviles","year":"2003","unstructured":"Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003;108:3006\u201310.","journal-title":"Circulation"},{"key":"1322_CR32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","volume":"352","author":"PM Ridker","year":"2005","unstructured":"Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005;352:20\u20138.","journal-title":"N Engl J Med"},{"key":"1322_CR33","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/01.CIR.0000095267.24234.00","volume":"108","author":"M Schillinger","year":"2003","unstructured":"Schillinger M, Exner M, Amighi J, Mlekusch W, Sabeti S, Rumpold H, et al. Joint effects of C-reactive protein and glycated hemoglobin in predicting future cardiovascular events of patients with advanced atherosclerosis. Circulation 2003;108:2323\u20138.","journal-title":"Circulation"},{"key":"1322_CR34","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/eurheartj\/ehi192","volume":"26","author":"I Ikonomidis","year":"2005","unstructured":"Ikonomidis I, Lekakis J, Revela I, Andreotti F, Nihoyannopoulos P. Increased circulating C-reactive protein and macrophage-colony stimulating factor are complementary predictors of long-term outcome in patients with chronic coronary artery disease. Eur Heart J 2005;26:1618\u201324.","journal-title":"Eur Heart J"},{"key":"1322_CR35","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1056\/NEJMoa043012","volume":"352","author":"X Jouven","year":"2005","unstructured":"Jouven X, Empana JP, Schwartz PJ, Desnos M, Courbon D, Ducimeti\u00e8re P. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 2005;352:1951\u20138.","journal-title":"N Engl J Med"},{"key":"1322_CR36","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ehj.2003.12.003","volume":"25","author":"A Sajadieh","year":"2004","unstructured":"Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 2004;25:363\u201370.","journal-title":"Eur Heart J"},{"key":"1322_CR37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.carpath.2007.07.007","volume":"17","author":"GF Diakakis","year":"2008","unstructured":"Diakakis GF, Parthenakis FI, Patrianakos AP, Koukouraki SI, Stathaki MI, Karkavitsas NS, et al. Myocardial sympathetic innervation in patients with impaired glucose tolerance: relationship to subclinical inflammation. Cardiovasc Pathol 2008;17:172\u20137.","journal-title":"Cardiovasc Pathol"},{"key":"1322_CR38","first-page":"1172","volume":"26","author":"GJ Maestroni","year":"1998","unstructured":"Maestroni GJ, Cosentino M, Marino F, Togni M, Conti A, Lecchini S, et al. Neural and endogenous catecholamines in the bone marrow. Circadian association of norepinephrine with hematopoiesis? Exp Hematol 1998;26:1172\u20137.","journal-title":"Exp Hematol"},{"key":"1322_CR39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0192-0561(94)90067-1","volume":"16","author":"GJ Maestroni","year":"1994","unstructured":"Maestroni GJ, Conti A. Noradrenergic modulation of lymphohematopoiesis. Int J Immunopharmacol 1994;16:117\u201322.","journal-title":"Int J Immunopharmacol"},{"key":"1322_CR40","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1152\/japplphysiol.00892.2002","volume":"94","author":"R Kanel von","year":"2003","unstructured":"von Kanel R, Dimsdale JE, Adler KA, Dillon E, Perez CJ, Mills PJ. Effects of nonspecific beta-adrenergic stimulation and blockade on blood coagulation in hypertension. J Appl Physiol 2003;94:1455\u20139.","journal-title":"J Appl Physiol"},{"key":"1322_CR41","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1034\/j.1600-0609.2000.065006357.x","volume":"65","author":"R K\u00e4nel von","year":"2000","unstructured":"von K\u00e4nel R, Dimsdale JE. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol 2000;65:357\u201369.","journal-title":"Eur J Haematol"},{"key":"1322_CR42","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1172\/JCI119674","volume":"100","author":"P Panina-Bordignon","year":"1997","unstructured":"Panina-Bordignon P, Mazzeo D, Lucia PD, D\u2019Ambrosio D, Lang R, Fabbri L, et al. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest 1997;100:1513\u201319.","journal-title":"J Clin Invest"},{"key":"1322_CR43","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0031-6997(24)01470-4","volume":"52","author":"IJ Elenkov","year":"2000","unstructured":"Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve\u2014an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000;52:595\u2013638.","journal-title":"Pharmacol Rev"},{"key":"1322_CR44","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/01.CIR.104.2.174","volume":"104","author":"MJ Mihm","year":"2001","unstructured":"Mihm MJ, Yu F, Carnes CA, Reiser PJ, McCarthy PM, Van Wagoner DR, et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 2001;104:174\u201380.","journal-title":"Circulation"},{"key":"1322_CR45","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijcard.2005.05.017","volume":"108","author":"M Acevedo","year":"2006","unstructured":"Acevedo M, Corbal\u00e1n R, Braun S, Pereira J, Navarrete C, Gonzalez I. C-reactive protein and atrial fibrillation: \u201cevidence for the presence of inflammation in the perpetuation of the arrhythmia\u201d. Int J Cardiol 2006;108:326\u201331.","journal-title":"Int J Cardiol"},{"key":"1322_CR46","first-page":"RA225","volume":"9","author":"P Korantzopoulos","year":"2003","unstructured":"Korantzopoulos P, Kolettis T, Siogas K, Goudevenos J. Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress. Med Sci Monit 2003;9:RA225\u20139.","journal-title":"Med Sci Monit"},{"key":"1322_CR47","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00259-008-0976-x","volume":"36","author":"D Agostini","year":"2009","unstructured":"Agostini D, Carrio I, Verberne HJ. How to use myocardial 123I-MIBG scintigraphy in chronic heart failure. Eur J Nucl Med Mol Imaging 2009;36:555\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1322_CR48","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1071-3581(03)00652-4","volume":"10","author":"Y Inoue","year":"2003","unstructured":"Inoue Y, Suzuki A, Shirouzu I, Machida T, Yoshizawa Y, Akita F, et al. Effect of collimator choice on quantitative assessment of cardiac iodine 123 MIBG uptake. J Nucl Cardiol 2003;10:623\u201332.","journal-title":"J Nucl Cardiol"},{"key":"1322_CR49","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s00259-005-1810-3","volume":"32","author":"HJ Verberne","year":"2005","unstructured":"Verberne HJ, Feenstra C, de Jong WM, Somsen GA, van Eck-Smit BLF, Busemann Sokole EB. Influence of collimator choice and simulated clinical conditions on 123I-MIBG heart\/mediastinum ratios: a phantom study. Eur J Nucl Med Mol Imaging 2005;32:1100\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-009-1322-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-009-1322-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-009-1322-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T21:24:39Z","timestamp":1739481879000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-009-1322-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,17]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["1322"],"URL":"https:\/\/doi.org\/10.1007\/s00259-009-1322-7","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,17]]}}}